National Comprehensive Cancer Network   Report issue

Foundation Phase 1 Phase 2
Founded: Plymouth Meeting PA United States (1995)

Organization Overview

First Clinical Trial
2003
NCT00346801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

National Comprehensive Cancer Network